AIM
SNOA icon

Advantage Investment Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Advantage Investment Management’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1
Closed – – 1010
2016
Q3 		$0 Hold
1
– – ﹤0.01% 955
2016
Q2 		$0 Hold
1
– – ﹤0.01% 910
2016
Q1 		$0 Buy
+1
New +$929 ﹤0.01% 917

Other funds holding SNOA

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advantage Investment Management's SNOA Position: Q4 2016 in Review

Advantage Investment Management sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2016, closing a stake of 1 share.

Advantage Investment Management first reported a position in SNOA in Q1 2016 and held it in 3 quarters. The position peaked at $0 in Q3 2016. 21 funds tracked by Wall St. Rank hold SNOA as of Q4 2016.

  • Advantage Investment Management reported no remaining Sonoma Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Advantage Investment Management sold 1 Sonoma Pharmaceuticals share in Q4 2016.
  • Advantage Investment Management first reported a position in Sonoma Pharmaceuticals in Q1 2016 and held it in 3 quarters.
  • Advantage Investment Management's Sonoma Pharmaceuticals position peaked at $0 in Q3 2016.
  • 21 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2016.

Based on Advantage Investment Management's 13F filing for Q4 2016, filed 17 Feb 2017.